Q1 2022 Presentation—Page 4

Q1 2022 Presentation22 Investor presentation First three months of 2022 Novo Nordisk Corporate Strategy Rare diseasePage 3Page 5

iPaper

Link copied to clipboard

▲ Link copied to clipboard

Download PDF file

...